Literature DB >> 16671440

Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.

Y Shigemori1, Y Katayama, T Mori, T Maeda, T Kawamata.   

Abstract

Matrix metalloproteinases (MMPs) are associated with blood-brain opening and may be involved in the pathophysiology of acute brain injury. Previous research demonstrated that knockout mice deficient in MMP-9 subjected to transient focal cerebral ischemia had reduced blood-brain barrier (BBB) disruption and attenuated cerebral infarction. In this study, we examined MMP-9 up-regulation, BBB disruption, and brain edema formation after cortical impact injury in rats. Cortical contusion was induced by controlled cortical impact. Animals were sacrificed at intervals after injury. MMP up-regulation was assessed by gelatin zymography, and BBB integrity was evaluated using Evans blue dye with a spectrophotometric assay. Brain water content was measured by comparing wet and dry weights of each hemisphere as an indicator of brain edema. Zymograms showed elevated MMP-9 as early as at 3 hours after injury, reaching a maximum at 18 hours. Peak levels of BBB disruption occurred 6 hours after injury. Brain edema became progressively more severe, peaking 24 hours after injury. Compared to control group, treatment with MMP-inhibitor GM6001 significantly reduced BBB disruption 6 hours and brain water content (85.9 +/- 0.5% vs. 82.6 +/- 0.3%; p < 0.05) 24 hours after injury. These findings suggest that MMP-9 may contribute to BBB disturbance and subsequent brain edema after traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16671440     DOI: 10.1007/3-211-30714-1_29

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  62 in total

Review 1.  Resveratrol neuroprotection in stroke and traumatic CNS injury.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2015-08-12       Impact factor: 3.921

Review 2.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 3.  Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift.

Authors:  Yasir N Jassam; Saef Izzy; Michael Whalen; Dorian B McGavern; Joseph El Khoury
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

4.  Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.

Authors:  Nino Muradashvili; Richard L Benton; Kathryn E Saatman; Suresh C Tyagi; David Lominadze
Journal:  Metab Brain Dis       Date:  2014-04-29       Impact factor: 3.584

Review 5.  Chloride Dysregulation, Seizures, and Cerebral Edema: A Relationship with Therapeutic Potential.

Authors:  Joseph Glykys; Volodymyr Dzhala; Kiyoshi Egawa; Kristopher T Kahle; Eric Delpire; Kevin Staley
Journal:  Trends Neurosci       Date:  2017-04-18       Impact factor: 13.837

Review 6.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

7.  Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.

Authors:  Mark Grossetete; Jeremy Phelps; Leopold Arko; Howard Yonas; Gary A Rosenberg
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

8.  Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Authors:  Borhane Annabi; Eric Vaillancourt-Jean; Alexander G Weil; Richard Béliveau
Journal:  Onco Targets Ther       Date:  2010-11-15       Impact factor: 4.147

9.  Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases.

Authors:  Anna Vilalta; Juan Sahuquillo; Anna Rosell; Maria A Poca; Marilyn Riveiro; Joan Montaner
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

10.  The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.

Authors:  Michael V DeFazio; Richard A Rammo; Jaime R Robles; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  World Neurosurg       Date:  2013-01-08       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.